Sign up to save your podcasts
Or
Share Monkeypox Is Spreading Rapidly
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Monkeypox Is Spreading Rapidly
Vidcast: https://youtu.be/utqGh5aJvwg
Monkeypox, the orthopox viral infection typically only occurring in Africa, is rapidly spreading around the world. As of August 4th, the total number of worldwide cases was 26,864 with all but 345 occurring in countries where this disease has not been previously reported.
Though not usually fatal, at least 77 Africans have died and an additional 5 deaths have been reported outside of Africa.
The total number of confirmed US monkeypox cases as of August 4th is 7102 with cases occurring in every state except Montana and Wyoming. Most current US cases associated with male-male sexual intimacy. The states hit the hardest are New York, Florida, Illinois, Texas, and California.
The last major US outbreak occurred in 2003 with 47 confirmed or probable cases in 6 states, Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, traced to infected pet prairie dogs that had been housed near imported small mammals from Africa. Then, in 2021, two isolated cases of monkeypox were diagnosed in Maryland and in Texas when US residents contracted the disease on trips to Africa.
Current efforts to stop the monkeypox epidemic include vaccination and use of anti-viral agents. A vaccination drive using the Danish monkeypox vaccine Jynneos or the older vaccinia viral vaccine ACAM2000 is underway but hampered by a vaccine shortage. The available supply is being optimized by only administering the first of 2 recommended doses, and virologists estimate that even this one dose offers 2 years of protection.
The best defense is avoidance of person-to-person contact with a monkeypox-infected person or their personal articles as the virus can live for weeks on objects. Those who have a social or occupational exposure to monkeypox including medical teams and diagnostic lab personnel should receive monkeypox pre-exposure prophylaxis or PrEP and that is vaccination.
How do you know you have monkeypox? Non-specific signs of illness such as fever and chills, headache, muscle aches, fatigue are accompanied by or followed by the appearance of a rash that can be all over your body or more likely limited to points of contact where you contracted the disease.
The antiviral agent tecovirimat, TPOXX for short, is effective against monkeypox and prescribed for the most severe cases or in those with complicating medical problems.
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
https://allafrica.com/view/group/main/main/id/00082929.html
#monkeypox #Jynneos #acam2000 #vaccination #tpoxx #tecovirimat
View all episodes
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/utqGh5aJvwg
Monkeypox, the orthopox viral infection typically only occurring in Africa, is rapidly spreading around the world. As of August 4th, the total number of worldwide cases was 26,864 with all but 345 occurring in countries where this disease has not been previously reported.
Though not usually fatal, at least 77 Africans have died and an additional 5 deaths have been reported outside of Africa.
The total number of confirmed US monkeypox cases as of August 4th is 7102 with cases occurring in every state except Montana and Wyoming. Most current US cases associated with male-male sexual intimacy. The states hit the hardest are New York, Florida, Illinois, Texas, and California.
The last major US outbreak occurred in 2003 with 47 confirmed or probable cases in 6 states, Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, traced to infected pet prairie dogs that had been housed near imported small mammals from Africa. Then, in 2021, two isolated cases of monkeypox were diagnosed in Maryland and in Texas when US residents contracted the disease on trips to Africa.
Current efforts to stop the monkeypox epidemic include vaccination and use of anti-viral agents. A vaccination drive using the Danish monkeypox vaccine Jynneos or the older vaccinia viral vaccine ACAM2000 is underway but hampered by a vaccine shortage. The available supply is being optimized by only administering the first of 2 recommended doses, and virologists estimate that even this one dose offers 2 years of protection.
The best defense is avoidance of person-to-person contact with a monkeypox-infected person or their personal articles as the virus can live for weeks on objects. Those who have a social or occupational exposure to monkeypox including medical teams and diagnostic lab personnel should receive monkeypox pre-exposure prophylaxis or PrEP and that is vaccination.
How do you know you have monkeypox? Non-specific signs of illness such as fever and chills, headache, muscle aches, fatigue are accompanied by or followed by the appearance of a rash that can be all over your body or more likely limited to points of contact where you contracted the disease.
The antiviral agent tecovirimat, TPOXX for short, is effective against monkeypox and prescribed for the most severe cases or in those with complicating medical problems.
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
https://allafrica.com/view/group/main/main/id/00082929.html
#monkeypox #Jynneos #acam2000 #vaccination #tpoxx #tecovirimat